心力衰竭患者的 COVID-19疫苗接种：欧洲心脏病学会心力衰竭协会的立场文件

2021-10-01 欧洲心脏病学会 Eur J Heart Fail . 2021 Oct 6. doi: 10.1002/ejhf.2356

感染 SARS-CoV-2 的心力衰竭 (HF) 患者心血管和非心血管疾病的发病率和死亡率风险更高。无论 COVID-19 的治疗尝试如何，疫苗接种仍然是目前控制这种疾病最有希望的全球方法。对于 HF

中文标题：

英文标题：

COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology

发布机构：

欧洲心脏病学会

发布日期：

2021-10-01

简要介绍：

感染 SARS-CoV-2 的心力衰竭 (HF) 患者心血管和非心血管疾病的发病率和死亡率风险更高。无论 COVID-19 的治疗尝试如何，疫苗接种仍然是目前控制这种疾病最有希望的全球方法。对于 HF 患者 COVID-19 疫苗的临床适应症、最佳给药方式、安全性和有效性，存在一些担忧和误解。本文件为所有医疗保健专业人员提供有关在 HF 患者中实施 COVID-19 疫苗接种计划的指导。 COVID-19 疫苗适用于所有 HF 患者，包括免疫功能低下（例如接受免疫抑制治疗的心脏移植后）和虚弱综合征患者。最好在最佳临床状态下对 COVID-19 心衰患者进行疫苗接种，包括临床稳定性、充足的水分和营养、心衰和其他合并症（包括缺铁）的优化治疗，但不应允许采取纠正措施延迟接种。已接种 COVID-19 疫苗的 HF 患者需要继续采取预防措施，包括戴口罩、保持手部卫生和保持社交距离。向心衰患者提供的综合教育计划中应包括预防 SARS-CoV-2 感染策略（包括 COVID-19 疫苗接种）的知识。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=de72f1c0022a697a, title=心力衰竭患者的 COVID-19疫苗接种：欧洲心脏病学会心力衰竭协会的立场文件 , enTitle=COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology, guiderFrom=Eur J Heart Fail . 2021 Oct 6. doi: 10.1002/ejhf.2356, authorId=0, author=, summary=感染 SARS-CoV-2 的心力衰竭 (HF) 患者心血管和非心血管疾病的发病率和死亡率风险更高。无论 COVID-19 的治疗尝试如何，疫苗接种仍然是目前控制这种疾病最有希望的全球方法。对于 HF, cover=, journalId=0, articlesId=null, associationId=62, associationName=欧洲心脏病学会, associationIntro=是目前在欧洲居于首要地位的心脏病学会，会员超过70000人、提供更新指南、调查数据、组织学术会议，ESC年会是心血管领域最大的会议。下设5个分会（超声心动图学会、心律学会、心衰学会、预防与康复学会及介入学会）。提供指南较全面，按年份排列。现提供有手机板本。, copyright=0, guiderPublishedTime=Fri Oct 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=感染 SARS-CoV-2 的心力衰竭 (HF) 患者心血管和非心血管疾病的发病率和死亡率风险更高。无论 COVID-19 的治疗尝试如何，疫苗接种仍然是目前控制这种疾病最有希望的全球方法。对于 HF 患者 COVID-19 疫苗的临床适应症、最佳给药方式、安全性和有效性，存在一些担忧和误解。本文件为所有医疗保健专业人员提供有关在 HF 患者中实施 COVID-19 疫苗接种计划的指导。 COVID-19 疫苗适用于所有 HF 患者，包括免疫功能低下（例如接受免疫抑制治疗的心脏移植后）和虚弱综合征患者。最好在最佳临床状态下对 COVID-19 心衰患者进行疫苗接种，包括临床稳定性、充足的水分和营养、心衰和其他合并症（包括缺铁）的优化治疗，但不应允许采取纠正措施延迟接种。已接种 COVID-19 疫苗的 HF 患者需要继续采取预防措施，包括戴口罩、保持手部卫生和保持社交距离。向心衰患者提供的综合教育计划中应包括预防 SARS-CoV-2 感染策略（包括 COVID-19 疫苗接种）的知识。, tagList=[TagDto(tagId=335, tagName=心力衰竭)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1476, appHits=39, showAppHits=0, pcHits=306, showPcHits=1437, likes=0, shares=2, comments=5, approvalStatus=1, publishedTime=Mon Nov 01 23:02:42 CST 2021, publishedTimeString=2021-10-01, pcVisible=1, appVisible=1, editorId=4754896, editor=小小医者, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=小小医者, createdTime=Sun Oct 31 21:45:38 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Sat Jan 06 22:11:29 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=1.pdf)])

1.pdf

下载请点击：

评论区 (5)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1074212, encodeId=273410e4212cc, content=不错学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:12:06 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066679, encodeId=2a9110666e903, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211017/06579159c2b1435d8909b4807c99bd19/c758f2fa7e19486bac3bc3b90f0e40e0.jpg, createdBy=65493672398, createdName=勇往直前称, createdTime=Wed Nov 03 19:53:14 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066088, encodeId=32f2106608809, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f1f5633705, createdName=ms1000000251410274, createdTime=Tue Nov 02 07:02:19 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066029, encodeId=821e10660291d, content=感谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Tue Nov 02 00:02:29 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066011, encodeId=950a10660116b, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Mon Nov 01 23:04:48 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
2021-11-26 H8888888

不错学习了

76 0
[GetPortalCommentsPageByObjectIdResponse(id=1074212, encodeId=273410e4212cc, content=不错学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:12:06 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066679, encodeId=2a9110666e903, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211017/06579159c2b1435d8909b4807c99bd19/c758f2fa7e19486bac3bc3b90f0e40e0.jpg, createdBy=65493672398, createdName=勇往直前称, createdTime=Wed Nov 03 19:53:14 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066088, encodeId=32f2106608809, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f1f5633705, createdName=ms1000000251410274, createdTime=Tue Nov 02 07:02:19 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066029, encodeId=821e10660291d, content=感谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Tue Nov 02 00:02:29 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066011, encodeId=950a10660116b, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Mon Nov 01 23:04:48 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
2021-11-03 勇往直前称

学习了

76 0
[GetPortalCommentsPageByObjectIdResponse(id=1074212, encodeId=273410e4212cc, content=不错学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:12:06 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066679, encodeId=2a9110666e903, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211017/06579159c2b1435d8909b4807c99bd19/c758f2fa7e19486bac3bc3b90f0e40e0.jpg, createdBy=65493672398, createdName=勇往直前称, createdTime=Wed Nov 03 19:53:14 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066088, encodeId=32f2106608809, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f1f5633705, createdName=ms1000000251410274, createdTime=Tue Nov 02 07:02:19 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066029, encodeId=821e10660291d, content=感谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Tue Nov 02 00:02:29 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066011, encodeId=950a10660116b, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Mon Nov 01 23:04:48 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
2021-11-02 ms1000000251410274

学习

86 0
[GetPortalCommentsPageByObjectIdResponse(id=1074212, encodeId=273410e4212cc, content=不错学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:12:06 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066679, encodeId=2a9110666e903, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211017/06579159c2b1435d8909b4807c99bd19/c758f2fa7e19486bac3bc3b90f0e40e0.jpg, createdBy=65493672398, createdName=勇往直前称, createdTime=Wed Nov 03 19:53:14 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066088, encodeId=32f2106608809, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f1f5633705, createdName=ms1000000251410274, createdTime=Tue Nov 02 07:02:19 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066029, encodeId=821e10660291d, content=感谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Tue Nov 02 00:02:29 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066011, encodeId=950a10660116b, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Mon Nov 01 23:04:48 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
2021-11-02 RENYUQIONG200798

感谢分享。

79 0
[GetPortalCommentsPageByObjectIdResponse(id=1074212, encodeId=273410e4212cc, content=不错学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:12:06 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066679, encodeId=2a9110666e903, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211017/06579159c2b1435d8909b4807c99bd19/c758f2fa7e19486bac3bc3b90f0e40e0.jpg, createdBy=65493672398, createdName=勇往直前称, createdTime=Wed Nov 03 19:53:14 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066088, encodeId=32f2106608809, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f1f5633705, createdName=ms1000000251410274, createdTime=Tue Nov 02 07:02:19 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066029, encodeId=821e10660291d, content=感谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85e91537175, createdName=RENYUQIONG200798, createdTime=Tue Nov 02 00:02:29 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066011, encodeId=950a10660116b, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Mon Nov 01 23:04:48 CST 2021, time=2021-11-01, status=1, ipAttribution=)]
2021-11-01 1207866fm50(暂无昵称)

谢谢分享

91 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管指南

心力衰竭患者的 COVID-19疫苗接种：欧洲心脏病学会心力衰竭协会的立场文件

相关指南

科室

工具

服务